Literature DB >> 3124902

Maternal administration of flecainide to terminate and suppress fetal tachycardia.

C Wren1, S Hunter.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3124902      PMCID： PMC2544772          DOI： 10.1136/bmj.296.6617.249

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN： 0267-0623


× No keyword cloud information.
  3 in total

1.  In utero diagnosis and treatment of fetal supraventricular tachycardia.

Authors:  C S Kleinman; J A Copel; E M Weinstein; T V Santulli; J C Hobbins
Journal:  Semin Perinatol       Date:  1985-07       Impact factor: 3.300

2.  The response of paediatric arrhythmias to intravenous and oral flecainide.

Authors:  C Wren; R W Campbell
Journal:  Br Heart J       Date:  1987-02

3.  Treatment of fetal cardiac arrhythmias.

Authors:  J W Wladimiroff; P A Stewart
Journal:  Br J Hosp Med       Date:  1985-09
  3 in total
  4 in total

Review 1.  Drug treatment of fetal tachycardias.

Authors:  Martijn A Oudijk; Jopje M Ruskamp; Barbara E Ambachtsheer; Tessa F F Ververs; Philip Stoutenbeek; Gerard H A Visser; Erik J Meijboom
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

2.  Transplacental pharmacokinetics of flecainide in the gravid baboon and fetus.

Authors:  V V Dimas; V V Dimasc; M D Taylor; C B Cunnyngham; E D Overholt; D W A Bourne; J R Stanely; A Sheikh; R Wolf; B Valentine; K E Ward
Journal:  Pediatr Cardiol       Date:  2005 Nov-Dec       Impact factor: 1.655

3.  Flecainide in the treatment of fetal tachycardias.

Authors:  L D Allan; S K Chita; G K Sharland; D Maxwell; K Priestley
Journal:  Br Heart J       Date:  1991-01

Review 4.  Fetal Arrhythmia Diagnosis and Pharmacologic Management.

Authors:  Janette F Strasburger; Gretchen Eckstein; Mary Butler; Patrick Noffke; Annette Wacker-Gussmann
Journal:  J Clin Pharmacol       Date:  2022-09       Impact factor: 2.860
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.